Texas Medical Center
1102 Bates Ave., Ste. 750.01
Houston, TX 77030
Karen R. Rabin, MD, PhD
Dr. Karen Rabin is Director of the Leukemia Program. Her clinical interests include acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Her research interests focus on prognosis, management, and genomics of ALL, with special interests in ALL in children with Down syndrome; and disparities in ALL outcomes in Hispanics.
American Board of Pediatrics - Pediatric Hematology/Oncology
American Board of Pediatrics - Pediatrics
Dr. Karen Rabin has research interests in genomics and management of childhood acute lymphoblastic leukemia (ALL), with particular areas of interest in ALL in children with Down syndrome, and disparities in childhood leukemia outcomes in Latinos. Dr. Rabin is a member of the Children’s Oncology Group (COG) ALL Executive Committee, Vice Chair of ALL Biology for COG, and Vice Chair of the current COG trial AALL1731 for children with Standard Risk and Down Syndrome ALL.
2021 Children’s Oncology Group Young Investigators Committee Award for Excellence in Mentoring
2021 Power of Professionalism Award, Baylor College of Medicine
2012 Fulbright & Jaworski Faculty Education Award for Excellence in Teaching and Evaluation
2010-2015 St. Baldrick’s Foundation Research Scholar
2009-2010 Hyundai Pediatric Cancer Research Scholar
2005-2009 K12 Faculty Fellowship in Pediatric Oncology Clinical Research
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.